Insider Purchases: Inside the Buy

Tag: NYSE BSX

Boston Scientific (BSX) investment illustration featuring a heart, stock chart recovery, CEO insider buying, 0.71 PEG ratio, $3.7 billion free cash flow, and institutional ownership highlighting a long-term healthcare investment opportunity.

🫀 Boston Scientific (BSX): The CEO Just Bought $9 Million. Is Wall Street Missing Something?

Boston Scientific's stock has been cut nearly in half from its peak, yet the business remains fundamentally strong. With CEO Mike Mahoney buying $9 million worth of shares, a remarkably low 0.71 PEG ratio, billions in annual free cash flow, and overwhelming institutional ownership, is Wall Street overlooking one of healthcare's most attractive GARP opportunities?

Read entire article

Tags: Boston Scientific, BostonScientific, BSX, buy or sell BSX, Cardiovascular, CEO BUYS BSX, CEO Insider Buying, FARAPULSE, featured-insiders, Free Cash Flow, FUNanc1al, GARP, Growth Stocks, Healthcare Stocks, hub-insiders, hub-value, Insider Purchases, InsiderBuying, Long-Term Investing, Medical Devices, MedicalDevices, MedTech, Michael Mahoney, MikeMahoney, NYSE BSX, PEG Ratio, risks buying BSX, Stock Analysis, Value Investing, ValueInvesting, WATCHMAN, why buy BSX
Cinematic illustration of Boston Scientific as a futuristic medtech powerhouse, with glowing cardiovascular devices, a heart-shaped stock chart, doctors, investors, and a $2B buyback shield symbolizing healthcare innovation and a GARP stock opportunity.

🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse

Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.

Read entire article

Tags: Boston Scientific, BostonScientific, BSX, BSX stock, buy or sell BSX, cardiovascular devices, CardiovascularTech, dividend growth stocks, FARAPULSE, featured-insiders, FUNanc1al, GARP, GARP investing, growth stocks, healthcare investing, healthcare stocks, hub-insiders, insider buying, InsiderBuying, medical device stocks, medical technology, MedicalDevices, MedTech, medtech stocks, NYSE BSX, risks buying BSX, ShareRepurchase, stock buyback, stock market analysis, value investing, ValueInvesting, WATCHMAN FLX, why buy BSX